BioNote Inc (377740)

Currency in KRW
4,990
-40(-0.80%)
Closed·
High dividend Yield
377740 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,8755,080
52 wk Range
4,6556,320
Key Statistics
Bid/Ask
4,990.00 / 5,020.00
Prev. Close
5,030
Open
4,970
Day's Range
4,875-5,080
52 wk Range
4,655-6,320
Volume
94.68K
Average Volume (3m)
105.73K
1-Year Change
6.3966%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
377740 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
14-05-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -865.27%
Dividend Yield
4.53%
Industry Median 0.97%
Annualised payout
228.00
Paid annually
5-Years Growth
-
Growth Streak

377740 Income Statement

Compare 377740 to Peers and Sector

Metrics to compare
377740
Peers
Sector
Relationship
P/E Ratio
−5.8x−10.8x−0.5x
PEG Ratio
0.020.030.00
Price/Book
0.3x1.4x2.6x
Price / LTM Sales
4.3x2.9x3.2x
Upside (Analyst Target)
-33.3%55.3%
Fair Value Upside
Unlock13.8%9.7%Unlock

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.

Employees
298

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
265.36K0.26%1.33B
Other Institutional Investors
39.79M39.38%200.13B
Public Companies & Retail Investors
60.98M60.36%306.73B
Total
101.03M100.00%508.19B

FAQ

What Is the BioNote (377740) Share Price Today?

The BioNote share price today is 4,990.

What is the current BioNote (377740) share price and day range?

As of 19-05-2026, the BioNote share price is 4,990, with a previous close of 5,030. The share price has ranged from 4,875 to 5,080 today, while the 52-week range spans from 4,655 to 6,320.

What Is the BioNote Market Cap?

As of today, BioNote market cap is 508.99B.

Does BioNote Pay Dividends? What's The Current Dividend Yield?

The BioNote dividend yield is 4.58%.

What Is BioNote's Earnings Per Share (TTM)?

The BioNote EPS (TTM) is -865.

When Is the Next BioNote Earnings Date?

BioNote will release its next earnings report on 14-05-2026.

From a Technical Analysis Perspective, Is 377740 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does BioNote Trade On?

BioNote is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for BioNote?

The stock symbol for BioNote is "377740."

How Many Times Has BioNote Stock Split?

BioNote has split 0 times.

How Many Employees Does BioNote Have?

BioNote has 298 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.